CogniCare Pro
Increased Focus: Helps maintain concentration on daily tasks.
Improved Memory: Aids in retaining important information.
More Mental Energy: Provides a feeling of alertness and vitality.
Natural Ingredients: Made with natural components, ideal for those seeking healthy options.
No Side Effects: Users report a free experience from unwanted effects.
Stress Reduction: Contributes to a sense of calm and relaxation.
Easy to Use: Simple to integrate into daily routines.
Mood Support: May help improve mood and motivation.
Order 6 Bottles Or 3 Bottles And Get 2 Free Bonuses!
The company is not endorsed by, sponsored by, or affiliated with any of these organizations
- Chronic Inflammation Linked to Dementia – Alissa Sauer – 2018
- Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer’s disease – R Wang – 2005
- L-Carnitine Supplementation in Older Women. A Pilot Study on Aging Skeletal Muscle Mass and Function – AK Sawicka – 2018
- Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
- Effects of Tooth Loss and the Apolipoprotein E ɛ4 Allele on Mild Memory Impairment in the Fujiwara-kyo Study of Japan: A Nested Case-Control Study – N Okamoto – 2017
- Neuropsychological Training of Attention Improves MS-Related Fatigue: Results of a Randomized, Placebo-Controlled, Double-Blind Pilot Study – P Flachenecker – 2017
- Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies – ASA Manap – 2019
- Reduced Alzheimer’s disease pathology by St. John’s wort treatment is independent of hyperforin and facilitated by ABCC1 and microglia activation in mice – J Hofrichter – 2013
- Role of Striatal-Enriched Tyrosine Phosphatase in Neuronal Function – M Kamceva – 2016
10. In search for Alzheimer’s drug, a major STEP forward – KN Peart – 2014
11. A common STEP in the synaptic pathology of diverse neuropsychiatric disorders – MA Johnson – 2012
- A STEP forward in neural function and degeneration – ML Baum – 2010
- Inhibitor of the tyrosine phosphatase STEP reverses cognitive deficits in a mouse model of Alzheimer’s disease – J Xu – 2014
- Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer’s disease mouse model – Y Zhang – 2010
- Drug reverses brain deficits of Alzheimer’s in mouse model – Yale University – 2014
- Further evidence that controlling high blood pressure can reduce dementia, Alzheimer’s risk – 2019
- Blood Pressure and Dementia – a Comprehensive Review – SP Kennelly – 2009
- How the brain’s immune system could be harnessed to improve memory – RMIT University – 2020
- Alzheimer’s wake-up call – 2017
- Effects of phosphatidylserine in Alzheimer’s disease – T Crook – 2017
- Effect of Phosphatidylserine on Cerebral Glucose Metabolism in Alzheimer’s Disease – P Klinkhammer – 1990
- Efficacy of vinpotropile in the therapy of initial signs of cerebrovascular pathology – 2010
- Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial – C Calabrese – 2008